FHA
DFTX icon

Flagship Harbor Advisors’s Definium Therapeutics DFTX Stock Holding History

Flagship Harbor Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
+7,966
New +$197K 0.01% 579
2026
Q1 		– Sell
-8,721
Closed -$117K – 1615
2025
Q4 		$117K Buy
+8,721
New +$108K 0.01% 827

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Flagship Harbor Advisors's DFTX Position: Q2 2026 in Review

Flagship Harbor Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 7,966 shares worth $375K. The stake represents 0.01% of the portfolio and ranks #579 among its holdings. This is a return to the name: Flagship Harbor Advisors previously reported a position in DFTX as recently as Q4 2025.

Flagship Harbor Advisors first reported a position in DFTX in Q4 2025 and has held it in 2 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Flagship Harbor Advisors held 7,966 shares of Definium Therapeutics worth $375K as of Q2 2026.
  • Definium Therapeutics was a new Flagship Harbor Advisors position in Q2 2026.
  • Definium Therapeutics made up 0.01% of Flagship Harbor Advisors's portfolio in Q2 2026, its #579 holding.
  • Flagship Harbor Advisors first reported a position in Definium Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.